| Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas Nature genetics 45 (6), 602-612, 2013 | 785 | 2013 |
| Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients I Sultan, I Qaddoumi, S Yaser, C Rodriguez-Galindo, A Ferrari Journal of Clinical Oncology 27 (20), 3391-3397, 2009 | 510 | 2009 |
| Vismodegib exerts targeted efficacy against recurrent sonic hedgehog–subgroup medulloblastoma: results from phase II pediatric brain tumor consortium studies PBTC-025B and PBTC-032 GW Robinson, BA Orr, G Wu, S Gururangan, T Lin, I Qaddoumi, ... Journal of Clinical Oncology 33 (24), 2646, 2015 | 460 | 2015 |
| Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial J Fangusaro, A Onar-Thomas, TY Poussaint, S Wu, AH Ligon, ... The lancet oncology 20 (7), 1011-1022, 2019 | 374 | 2019 |
| Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology I Qaddoumi, W Orisme, J Wen, T Santiago, K Gupta, JD Dalton, B Tang, ... Acta neuropathologica 131, 833-845, 2016 | 359 | 2016 |
| A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study A Banerjee, RI Jakacki, A Onar-Thomas, S Wu, T Nicolaides, ... Neuro-oncology 19 (8), 1135-1144, 2017 | 298 | 2017 |
| Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas S Ryall, M Zapotocky, K Fukuoka, L Nobre, AG Stucklin, J Bennett, ... Cancer cell 37 (4), 569-583. e5, 2020 | 296 | 2020 |
| Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas A Lassaletta, M Zapotocky, M Mistry, V Ramaswamy, M Honnorat, ... Journal of Clinical Oncology 35 (25), 2934-2941, 2017 | 293 | 2017 |
| Challenging issues in pediatric oncology CH Pui, AJ Gajjar, JR Kane, IA Qaddoumi, AS Pappo Nature reviews Clinical oncology 8 (9), 540-549, 2011 | 252 | 2011 |
| Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database I Qaddoumi, I Sultan, A Gajjar Cancer: Interdisciplinary International Journal of the American Cancer …, 2009 | 240 | 2009 |
| Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators S Canturk, I Qaddoumi, V Khetan, Z Ma, A Furmanchuk, CBG Antoneli, ... British Journal of Ophthalmology 94 (11), 1432-1436, 2010 | 227 | 2010 |
| Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium D Bakry, M Aronson, C Durno, H Rimawi, R Farah, QK Alharbi, M Alharbi, ... European journal of cancer 50 (5), 987-996, 2014 | 216 | 2014 |
| Carboplatin-associated ototoxicity in children with retinoblastoma I Qaddoumi, JK Bass, J Wu, CA Billups, AW Wozniak, TE Merchant, ... Journal of Clinical Oncology 30 (10), 1034, 2012 | 185 | 2012 |
| Pineal gland tumors: experience from the SEER database M Al-Hussaini, I Sultan, N Abuirmileh, I Jaradat, I Qaddoumi Journal of neuro-oncology 94, 351-358, 2009 | 172 | 2009 |
| Retinoblastoma: one world, one vision C Rodriguez-Galindo, MW Wilson, G Chantada, L Fu, I Qaddoumi, ... Pediatrics 122 (3), e763-e770, 2008 | 170 | 2008 |
| Strategies to manage retinoblastoma in developing countries GL Chantada, I Qaddoumi, S Canturk, V Khetan, Z Ma, K Kimani, ... Pediatric blood & cancer 56 (3), 341-348, 2011 | 164 | 2011 |
| Teleoncology: current and future applications for improving cancer care globally R Hazin, I Qaddoumi The lancet oncology 11 (2), 204-210, 2010 | 164 | 2010 |
| St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas J Zhang, G Wu, CP Miller, RG Tatevossian, JD Dalton, B Tang, W Orisme, ... Nat Genet 45 (6), 602-612, 2013 | 139 | 2013 |
| Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors I Sultan, I Qaddoumi, C Rodríguez‐Galindo, AA Nassan, K Ghandour, ... Pediatric blood & cancer 54 (1), 35-40, 2010 | 128 | 2010 |
| Impact of telemedicine on pediatric neuro‐oncology in a developing country: The Jordanian‐Canadian experience I Qaddoumi, A Mansour, A Musharbash, J Drake, M Swaidan, T Tihan, ... Pediatric blood & cancer 48 (1), 39-43, 2007 | 117 | 2007 |
